201 related articles for article (PubMed ID: 35082969)
1. The Hypoxia-Related Gene COL5A1 Is a Prognostic and Immunological Biomarker for Multiple Human Tumors.
Zhu H; Hu X; Feng S; Jian Z; Xu X; Gu L; Xiong X
Oxid Med Cell Longev; 2022; 2022():6419695. PubMed ID: 35082969
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of pan-cancer reveals potential of ASF1B as a prognostic and immunological biomarker.
Hu X; Zhu H; Zhang X; He X; Xu X
Cancer Med; 2021 Oct; 10(19):6897-6916. PubMed ID: 34472711
[TBL] [Abstract][Full Text] [Related]
3. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
4. Overexpressed COL5A1 is correlated with tumor progression, paclitaxel resistance, and tumor-infiltrating immune cells in ovarian cancer.
Zhang J; Zhang J; Wang F; Xu X; Li X; Guan W; Men T; Xu G
J Cell Physiol; 2021 Oct; 236(10):6907-6919. PubMed ID: 33655494
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
Liu P; Wang X; Pan L; Han B; He Z
Front Immunol; 2022; 13():901784. PubMed ID: 35720327
[TBL] [Abstract][Full Text] [Related]
6. Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role.
Zhu H; Hu X; Ye Y; Jian Z; Zhong Y; Gu L; Xiong X
Front Genet; 2021; 12():687778. PubMed ID: 34594356
[TBL] [Abstract][Full Text] [Related]
7. GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer.
Chen G; Luo D; Zhong N; Li D; Zheng J; Liao H; Li Z; Lin X; Chen Q; Zhang C; Lu Y; Chan YT; Ren Q; Wang N; Feng Y
Front Immunol; 2022; 13():857308. PubMed ID: 35345673
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and immunological role of Ras-related protein Rap1b in pan-cancer.
Cui G; Wang C; Lin Z; Feng X; Wei M; Miao Z; Sun Z; Wei F
Bioengineered; 2021 Dec; 12(1):4828-4840. PubMed ID: 34346294
[TBL] [Abstract][Full Text] [Related]
9. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.
Chen P; Xu J; Cui Z; Wu S; Xie T; Zhang X
Front Immunol; 2023; 14():1071675. PubMed ID: 36761737
[TBL] [Abstract][Full Text] [Related]
10. COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas.
Gu S; Peng Z; Wu Y; Wang Y; Lei D; Jiang X; Zhao H; Fu P
Front Oncol; 2021; 11():752694. PubMed ID: 34868960
[TBL] [Abstract][Full Text] [Related]
11. A pan-cancer analysis of RNASEH1, a potential regulator of the tumor microenvironment.
Yi C; Yang J; Zhang T; Xie S; Li W; Qin L; Chen D
Clin Transl Oncol; 2023 Aug; 25(8):2569-2586. PubMed ID: 37022517
[TBL] [Abstract][Full Text] [Related]
12. A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance.
Yang L; Zhang Y; Tang Y; Wang Y; Jiang P; Liu F; Feng N
Sci Rep; 2023 Apr; 13(1):5779. PubMed ID: 37031216
[TBL] [Abstract][Full Text] [Related]
13. NALCN is a potential biomarker and therapeutic target in human cancers.
He J; Xu J; Chang Z; Yan J; Zhang L; Qin Y
Front Genet; 2023; 14():1164707. PubMed ID: 37152978
[No Abstract] [Full Text] [Related]
14. ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis.
Lin Y; Zhang Y; Tuo Z; Gao L; Ding D; Bi L; Yu D; Lv Z; Wang J; Chen X
BMC Cancer; 2023 Mar; 23(1):285. PubMed ID: 36978046
[TBL] [Abstract][Full Text] [Related]
15. Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistry.
Wu M; Sun Q; Mo CH; Pang JS; Hou JY; Pang LL; Lu HP; Dang YW; Fang SJ; Tang D; Chen G; Feng ZB
Oncol Rep; 2019 Jul; 42(1):151-175. PubMed ID: 31059074
[TBL] [Abstract][Full Text] [Related]
16. A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.
Zhou X; Du J; Liu C; Zeng H; Chen Y; Liu L; Wu D
Front Immunol; 2021; 12():688215. PubMed ID: 34305920
[TBL] [Abstract][Full Text] [Related]
17. Integrative Pan-Cancer Analysis Confirmed that FCGR3A is a Candidate Biomarker Associated With Tumor Immunity.
Li L; Huang Z; Du K; Liu X; Li C; Wang D; Zhang Y; Wang C; Li J
Front Pharmacol; 2022; 13():900699. PubMed ID: 35668930
[No Abstract] [Full Text] [Related]
18. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
19. Immune Infiltration of MMP14 in Pan Cancer and Its Prognostic Effect on Tumors.
Li M; Li S; Zhou L; Yang L; Wu X; Tang B; Xie S; Fang L; Zheng S; Hong T
Front Oncol; 2021; 11():717606. PubMed ID: 34604053
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker.
Niu H; Chen P; Fan L; Sun B
BMC Med Genomics; 2022 Feb; 15(1):29. PubMed ID: 35172803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
